Family Care Hospitals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 1, 2025, 3:39 pm

Quick Insight

Family Care Hospitals Ltd, with a current share price of ₹4.34 and a market cap of 23.4 Cr., presents an intriguing investment opportunity in the Hospitals & Medical Services sector. Despite a low P/E ratio of 0.74, the company boasts an impressive ROE of 84.8% and ROCE of 77.2%, indicating strong profitability and efficient capital utilization. However, the negative OPM of -5,200.00% raises concerns about operational efficiency, while the Net Profit of -44 and negative Reserves of -41 Cr. highlight financial challenges. With a high Promoter holding of 18.54% and healthy ICR of 110.60x, investors should closely monitor the company's ability to turn around its operational performance and address its financial liabilities to unlock its true intrinsic value and potential for growth in the long term.

Competitors of Family Care Hospitals Ltd

All Competitor Stocks of Family Care Hospitals Ltd

Quarterly Result

Last Updated: July 16, 2025, 9:58 am

Below is a detailed analysis of the quarterly data for Family Care Hospitals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Dec 2024) to 0.02 Cr., marking a decrease of 0.01 Cr..
• For Expenses, as of Mar 2025, the value is 1.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.78 Cr. (Dec 2024) to 1.06 Cr., marking a decrease of 0.72 Cr..
• For Operating Profit, as of Mar 2025, the value is -1.04 Cr.. The value appears strong and on an upward trend. It has increased from -1.75 Cr. (Dec 2024) to -1.04 Cr., marking an increase of 0.71 Cr..
• For OPM %, as of Mar 2025, the value is -5,200.00%. The value appears strong and on an upward trend. It has increased from -5,833.33% (Dec 2024) to -5,200.00%, marking an increase of 633.33%.
• For Other Income, as of Mar 2025, the value is 2.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2024) to 2.03 Cr., marking an increase of 2.03 Cr..
• For Interest, as of Mar 2025, the value is 0.07 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.07 Cr..
• For Depreciation, as of Mar 2025, the value is 0.25 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.28 Cr. (Dec 2024) to 0.25 Cr., marking a decrease of 0.03 Cr..
• For Profit before tax, as of Mar 2025, the value is 0.67 Cr.. The value appears strong and on an upward trend. It has increased from -2.10 Cr. (Dec 2024) to 0.67 Cr., marking an increase of 2.77 Cr..
• For Tax %, as of Mar 2025, the value is -47.76%. The value appears to be improving (decreasing) as expected. It has decreased from 0.00% (Dec 2024) to -47.76%, marking a decrease of 47.76%.
• For Net Profit, as of Mar 2025, the value is 0.99 Cr.. The value appears strong and on an upward trend. It has increased from -2.10 Cr. (Dec 2024) to 0.99 Cr., marking an increase of 3.09 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.18. The value appears strong and on an upward trend. It has increased from -0.39 (Dec 2024) to 0.18, marking an increase of 0.57.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:30 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:19 pm

Below is a detailed analysis of the balance sheet data for Family Care Hospitals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 54.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 54.00 Cr..
• For Reserves, as of Mar 2025, the value is -41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2024) to -41.00 Cr., marking a decrease of 45.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 4.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2024) to 29.00 Cr., marking an increase of 21.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 46.00 Cr.. The value appears to be improving (decreasing). It has decreased from 70.00 Cr. (Mar 2024) to 46.00 Cr., marking a decrease of 24.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Mar 2024) to 42.00 Cr., marking a decrease of 22.00 Cr..
• For Total Assets, as of Mar 2025, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Mar 2024) to 46.00 Cr., marking a decrease of 24.00 Cr..

However, the Borrowings (3.00 Cr.) are higher than the Reserves (-41.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Family Care Hospitals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 23, the value is -8.17. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 22) to -8.17, marking a decrease of 10.49.
• For Diluted EPS (Rs.), as of Mar 23, the value is -8.17. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 22) to -8.17, marking a decrease of 10.49.
• For Cash EPS (Rs.), as of Mar 23, the value is -7.96. This value is below the healthy minimum of 3. It has decreased from 2.59 (Mar 22) to -7.96, marking a decrease of 10.55.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 2.49. It has decreased from 10.81 (Mar 22) to 2.49, marking a decrease of 8.32.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 2.49. It has decreased from 10.81 (Mar 22) to 2.49, marking a decrease of 8.32.
• For Dividend / Share (Rs.), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 22) which recorded 0.00.
• For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 1.46. It has decreased from 7.41 (Mar 22) to 1.46, marking a decrease of 5.95.
• For PBDIT / Share (Rs.), as of Mar 23, the value is 5.84. This value is within the healthy range. It has increased from 1.84 (Mar 22) to 5.84, marking an increase of 4.00.
• For PBIT / Share (Rs.), as of Mar 23, the value is 5.63. This value is within the healthy range. It has increased from 1.58 (Mar 22) to 5.63, marking an increase of 4.05.
• For PBT / Share (Rs.), as of Mar 23, the value is -8.23. This value is below the healthy minimum of 0. It has decreased from 1.50 (Mar 22) to -8.23, marking a decrease of 9.73.
• For Net Profit / Share (Rs.), as of Mar 23, the value is -8.17. This value is below the healthy minimum of 2. It has decreased from 2.32 (Mar 22) to -8.17, marking a decrease of 10.49.
• For PBDIT Margin (%), as of Mar 23, the value is 399.32. This value is within the healthy range. It has increased from 24.83 (Mar 22) to 399.32, marking an increase of 374.49.
• For PBIT Margin (%), as of Mar 23, the value is 385.07. This value exceeds the healthy maximum of 20. It has increased from 21.28 (Mar 22) to 385.07, marking an increase of 363.79.
• For PBT Margin (%), as of Mar 23, the value is -562.53. This value is below the healthy minimum of 10. It has decreased from 20.32 (Mar 22) to -562.53, marking a decrease of 582.85.
• For Net Profit Margin (%), as of Mar 23, the value is -558.47. This value is below the healthy minimum of 5. It has decreased from 31.36 (Mar 22) to -558.47, marking a decrease of 589.83.
• For Return on Networth / Equity (%), as of Mar 23, the value is -327.98. This value is below the healthy minimum of 15. It has decreased from 21.49 (Mar 22) to -327.98, marking a decrease of 349.47.
• For Return on Capital Employeed (%), as of Mar 23, the value is 219.07. This value is within the healthy range. It has increased from 14.21 (Mar 22) to 219.07, marking an increase of 204.86.
• For Return On Assets (%), as of Mar 23, the value is -95.77. This value is below the healthy minimum of 5. It has decreased from 17.93 (Mar 22) to -95.77, marking a decrease of 113.70.
• For Long Term Debt / Equity (X), as of Mar 23, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 22) to 0.01, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 23, the value is 0.25. This value is within the healthy range. It has increased from 0.06 (Mar 22) to 0.25, marking an increase of 0.19.
• For Asset Turnover Ratio (%), as of Mar 23, the value is 0.13. It has decreased from 0.55 (Mar 22) to 0.13, marking a decrease of 0.42.
• For Current Ratio (X), as of Mar 23, the value is 1.28. This value is below the healthy minimum of 1.5. It has decreased from 5.51 (Mar 22) to 1.28, marking a decrease of 4.23.
• For Quick Ratio (X), as of Mar 23, the value is 0.09. This value is below the healthy minimum of 1. It has decreased from 5.45 (Mar 22) to 0.09, marking a decrease of 5.36.
• For Interest Coverage Ratio (X), as of Mar 23, the value is 110.60. This value is within the healthy range. It has increased from 25.90 (Mar 22) to 110.60, marking an increase of 84.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 107.78. This value is within the healthy range. It has increased from 33.71 (Mar 22) to 107.78, marking an increase of 74.07.
• For Enterprise Value (Cr.), as of Mar 23, the value is 22.55. It has decreased from 23.96 (Mar 22) to 22.55, marking a decrease of 1.41.
• For EV / Net Operating Revenue (X), as of Mar 23, the value is 2.85. This value is within the healthy range. It has increased from 0.59 (Mar 22) to 2.85, marking an increase of 2.26.
• For EV / EBITDA (X), as of Mar 23, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 22) to 0.71, marking a decrease of 1.70.
• For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 2.45. This value is within the healthy range. It has increased from 0.94 (Mar 22) to 2.45, marking an increase of 1.51.
• For Price / BV (X), as of Mar 23, the value is 1.44. This value is within the healthy range. It has increased from 0.64 (Mar 22) to 1.44, marking an increase of 0.80.
• For Price / Net Operating Revenue (X), as of Mar 23, the value is 2.45. This value is within the healthy range. It has increased from 0.94 (Mar 22) to 2.45, marking an increase of 1.51.
• For EarningsYield, as of Mar 23, the value is -2.28. This value is below the healthy minimum of 5. It has decreased from 0.33 (Mar 22) to -2.28, marking a decrease of 2.61.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness